Literature DB >> 23104633

Solitary metachronous splenic metastasis from cutaneous melanoma.

Paschalis Gavriilidis1, Eleni Goupou.   

Abstract

Melanoma has been found to metastasise to the spleen, usually in cases of disseminated disease. Solitary splenic metastasis from cutaneous melanoma is very rare. Herein we report the case of a 43-year-old man who developed solitary splenic metastasis from cutaneous melanoma. The patient was operated for T(4b) N(1a) Mo superficial spreading melanoma of the anterior thoracic wall. He subsequently underwent left axillary lymph node dissection due to a positive sentinel lymph node. The 33 retrieved lymph nodes were negative for metastasis. The patient received adjuvant therapy with high-dose interferon α-2b. After 27 months and during the follow-up visit an increasing lactate dehydrogenase serum level was observed. Furthermore, CT of the whole body revealed a solitary hypodense tumour of the spleen 9 cm×6 cm. Curative splenectomy was performed and the histopathological report confirmed metastatic melanoma to the spleen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104633      PMCID: PMC4543598          DOI: 10.1136/bcr-2012-007317

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  METASTATIC MELANOMA OF THE GASTROINTESTINAL TRACT.

Authors:  T K DASGUPTA; R D BRASFIELD
Journal:  Arch Surg       Date:  1964-06

2.  Spontaneous (pathologic) rupture of spleen in malignancies.

Authors:  C P Karakousis; E G Elias
Journal:  Surgery       Date:  1974-10       Impact factor: 3.982

3.  Surgery for abdominal metastases of cutaneous melanoma.

Authors:  H Gutman; K R Hess; J A Kokotsakis; M I Ross; V F Guinee; C M Balch
Journal:  World J Surg       Date:  2001-06       Impact factor: 3.352

4.  Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?

Authors:  T F Wood; L A DiFronzo; D M Rose; P I Haigh; S L Stern; L Wanek; R Essner; D L Morton
Journal:  Ann Surg Oncol       Date:  2001-09       Impact factor: 5.344

5.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

6.  Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.

Authors:  Sanjiv S Agarwala; John Glaspy; Steven J O'Day; Malcolm Mitchell; John Gutheil; Eric Whitman; Rene Gonzalez; Evan Hersh; Lynn Feun; Robert Belt; Frank Meyskens; Kristoffer Hellstrand; Diana Wood; John M Kirkwood; Kurt R Gehlsen; Peter Naredi
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

7.  Giant splenomegaly caused by splenic metastases of melanoma.

Authors:  S Kyzer; R Koren; B Klein; C Chaimoff
Journal:  Eur J Surg Oncol       Date:  1998-08       Impact factor: 4.424

8.  Surgical treatment of splenic metastases in patients with melanoma.

Authors:  Johannes H W de Wilt; William H McCarthy; John F Thompson
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

9.  Analysis of 945 cases of pulmonary metastatic melanoma.

Authors:  D H Harpole; C M Johnson; W G Wolfe; S L George; H F Seigler
Journal:  J Thorac Cardiovasc Surg       Date:  1992-04       Impact factor: 5.209

Review 10.  Isolated splenic metastasis from rectal carcinoma.

Authors:  P J Capizzi; K B Allen; J R Amerson; J E Skandalakis
Journal:  South Med J       Date:  1992-10       Impact factor: 0.954

View more
  1 in total

1.  Metastatic melanoma of the spleen without known primary.

Authors:  Brian Dusseau; Bridget Onders; Andrei Radulescu; Matthew Abourezk; John Leff
Journal:  J Surg Case Rep       Date:  2020-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.